Discovery of seven new sites in the human genome found to influence obesity



Testosterone therapy may not be the magic bullet women with low libidos are hoping for, according to seasoned sex therapist Domeena Renshaw, MD. “Female sexual dysfunction is being treated as a medical problem with a quick fix, when in fact women’s libido issues may be more complicated,” said Renshaw, author, Seven Weeks to Better Sex,

Full Post: Female testosterone therapy no magic bullet for sexual dysfunction

In one of the largest studies of its kind, a multinational team led by scientists from deCODE genetics has reported the discovery of common variations at seven new sites in the human genome found to influence obesity.

The study analyzed more than 300,000 single-letter variations (SNPs) across the genome of more than 30,000 people from Iceland, the Netherlands, and the United States, and confirmed the findings in data from more than 40,000 individuals from Denmark and the US-based GIANT Consortium. deCODE is incorporating the novel SNPs on chromosomes 1, 2, 3, 6, 11, 12 and 19 reported today in its deCODEme(TM) personal genome analysis service, and subscribers will receive an update to their personal profiles. The paper, entitled “Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity,” is published today in the online edition of Nature Genetics at http://www.nature.com/ng, and will appear in an upcoming print edition of the journal.

“This study essentially doubles in one fell swoop the number of known and replicated genetic factors contributing to obesity as a public health problem. And what we are seeing in obesity are a large number of common genetic risk factors with a relatively modest impact on disease. One of the most notable aspects of these discoveries is that most of these new risk factors are near genes that regulate processes in the brain. This suggests that as we work to develop better means of combating obesity, including using these discoveries as the first step in developing new drugs, we need to focus on the regulation of appetite at least as much as on the metabolic factors of how the body uses and stores energy,” said Kari Stefansson, CEO of deCODE and senior author on the paper.

“Today’s findings also underscore our ability to employ our population-based resources and statistical knowhow in Iceland as a cornerstone of large-scale multinational collaborations to identify and replicate the inherited causes of the most complex phenotypes. These new variants may point to valuable new drug targets, and we are already integrating them into deCODEme.(TM) We look forward to expanding upon our productive collaboration with colleagues in the US and Europe to continue to increase our understanding of the biology that underlies obesity,” Dr. Stefansson added.

Obesity results from the consumption of more calories than the body uses, and it represents a growing public health problem worldwide, particularly in industrialized countries. Obesity is a major risk factor for diseases such as type 2 diabetes, a range of cardiovascular conditions, and even some forms of cancer. One third of the population of the United States is now classified as obese, and the World Health Organization (WHO) estimates that around the world as many as 400 million people are obese.

Obesity is a quintessentially complex condition. Behavioral factors such as diet, eating habits and lack of exercise play a major role, but these interact with genetic factors that influence the regulation of appetite as well as how the body uses energy and stores it as fat. The aim of the study published today was to identify more of these genetic factors as a means of better understanding the biological processes that contribute to obesity. This information can be used to inform efforts to develop better means of combatting it. The discovery phase of the study published today correlated more than 300,000 SNPs with data on weight and body mass index (BMI). BMI is a measure used to relate weight to height, calculated as an individual’s weight in kilograms divided by their height in meters squared, and individuals with a BMI greater than 30 are defined as obese. The 43 SNPs identified in this first scan were then analyzed in 5,500 Danes and genotypic data from the 33,000 participants in the GIANT Consortium’s research. This analysis yielded SNPs linked to overweight and obesity at seven regions of the genome not previously known to be involved in obesity; identified new SNPs at previously known obesity-linked sites in the genome; and confirmed and refined the impact on obesity of previously published SNPs at four other sites in the genome.

deCODE and the authors would like to thank the participants in this study, and to acknowledge the fruitful collaboration with the GIANT Consortium, which included data from this study in its own meta-analysis also published today. The research performed at deCODE was partly funded through the European Community’s ENGAGE project, grant agreement HEALTH-F4-2007-201413. Support for the US research was provided by the US National Institutes of Health, and for the Danish research by the Lundbeck Foundation Centre of Applied Medical Genomics and the Danish Health Research Council.

http://www.decodeme.com

Link




deCODE genetics has announced the discovery by an international consortium of scientists from deCODE and major European and US academic institutions of a single letter variation in the human genome (SNP) that is associated with increased fasting glucose levels and risk of type 2 diabetes (T2D). deCODE will employ its CLIA-registered genotyping laboratory and existing

Full Post: deCODE to integrate new genetic risk factor for type 2 diabetes into its personal genome scan service



Several presentations by deCODE genetics scientists and independent researchers at the American Heart Association Scientific Sessions 2008 being held at the New Orleans Convention Center from November 8 to12 are expected to expand upon the clinical utility of evaluating individual risk of heart attack, or atrial fibrillation and stroke, respectively, by measuring the genetic markers

Full Post: Data expands the clinical utility of deCODE tests for heart attack, atrial fibrillation and stroke



The international GIANT (Genetic Investigation of Anthropometric Parameters) consortium works on the discovery of obesity genes. So far, the scientists have analyzed two million DNA variations in 15 genome-wide association studies with a total of more than 32,000 participants. The hereby identified candidate genes were validated in 14 further studies including 59,000 participants. In addition

Full Post: Six more obesity genes identified



Three new genetic variations that increase the risk of obesity are revealed in a new study, published today in the journal Nature Genetics. The authors suggest that if each acted independently, these variants could be responsible for up to 50% of cases of severe obesity. Together with existing research, the new findings should ultimately provide

Full Post: Three new genetic variations that increase the risk of obesity



Obesity affects health in several ways, but new research shows obesity can have minimal impact on ovarian cancer survival. A study by researchers at the University of Alabama at Birmingham (UAB) Comprehensive Cancer Center found ovarian cancer survival rates are the same for obese and non-obese women if their chemotherapy doses are closely matched to

Full Post: Obesity has minimal impact on ovarian cancer survival